首页> 外文OA文献 >A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy

【2h】

A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy

机译：Campath-1H作为移植物抗宿主疾病策略的一部分，针对血液系统恶性肿瘤患者进行强度降低的条件疗法后进行异基因干细胞移植的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Shore Tsiporah; Harpel John; Schuster Michael W.; Roboz Gail J.; Leonard John P.; Coleman Morton; Feldman Eric J.; Silver Richard T.;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. [J] . Shore T, Harpel J, Schuster MW, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2006,第8期

机译：使用Campath-1H作为移植物抗宿主疾病策略的一部分，针对血液恶性肿瘤患者进行强度降低的条件疗法后进行同种异体干细胞移植的研究。
2. A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies [J] . Haverkos Brad, Cortright Katie, Andritsos Leslie A., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：Milatuzumab预防强度降低的异基因干细胞移植降低血液恶性肿瘤患者急性移植物抗宿主病的I期研究
3. Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J] . Monzr M. Al Malki, Nitya Nathwani, Dongyun Yang, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第9期

机译：基于Melphalan的减少强度调节与70岁的患者有良好的疾病控制和可接受的毒性有关，血液学恶性肿瘤患者经历了同种异体造血干细胞移植
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
6. Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies [O] . Arjun Datt Law, Maria Queralt Salas, Wilson Lam, -1

机译：降低强度的条件和抗胸腺球蛋白和移植后的环磷酰胺双重T细胞抑制作为移植对宿主疾病在血液系统恶性肿瘤单倍体造血干细胞移植中的预防
7. A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies [O] . Haverkos Brad, Cortright Katie, Andritsos Leslie A., 2015

机译：Milatuzumab预防强度降低的异基因干细胞移植在血液系统恶性肿瘤中的急性移植物抗宿主病的I期研究

A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy

著录项

相似文献

相关主题

期刊订阅